The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the detection of brown tumors: A case series

Salah Nabih Oueriagli , Ayoub Dribla , Omar Ait Sahel , Yassir Ben Ameur , Abderrahim Doudouh

Advances in Radiotherapy & Nuclear Medicine ›› 2025, Vol. 3 ›› Issue (1) : 97 -102.

PDF (1155KB)
Advances in Radiotherapy & Nuclear Medicine ›› 2025, Vol. 3 ›› Issue (1) : 97 -102. DOI: 10.36922/arnm.3540
CASE SERIES
research-article

The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the detection of brown tumors: A case series

Author information +
History +
PDF (1155KB)

Abstract

We present two cases of chronic hemodialysis patients with suspicious lytic pelvic bone lesions in the context of secondary hyperparathyroidism (HPT). Bone biopsies were inconclusive. 18F-fluorodeoxyglucose positron emission tomography/ computed tomography (18F-FDG PET/CT) scans revealed highly hypermetabolic lytic lacunar bone lesions scattered throughout the skeleton. Pathological 99mTc-hexakismethoxy- isobutyl-isonitrile (99mTc-MIBI) uptake in the cervical region suggested parathyroid tissue involvement, while whole-body 99mTc-MIBI scintigraphy did not reveal pathological uptake. Brown tumors were strongly suspected based on clinical and laboratory evidence of HPT, ruling out malignancy. Our cases suggest the superior sensitivity of 18F-FDG PET/CT in detecting and characterizing brown tumors compared to whole-body 99mTc-MIBI scintigraphy. This examination offers crucial insights into characterizing brown tumors based on morpho-metabolic criteria, minimizing inaccurate diagnosis of this pathological condition.

Keywords

Brown tumors / Positron emission tomography/computed tomography / 18F-fluorodeoxyglucose / Hyperparathyroidism

Cite this article

Download citation ▾
Salah Nabih Oueriagli, Ayoub Dribla, Omar Ait Sahel, Yassir Ben Ameur, Abderrahim Doudouh. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the detection of brown tumors: A case series. Advances in Radiotherapy & Nuclear Medicine, 2025, 3(1): 97-102 DOI:10.36922/arnm.3540

登录浏览全文

4963

注册一个新账户 忘记密码

Acknowledgments

None.

Funding

None.

Conflict of interest

The authors declare that they have no competing interests.

Author contributions

Conceptualization: Ayoub Dribla, Yassir Ben Ameur

Investigation: Ayoub Dribla, Omar Ait Sahel

Methodology: Salah Nabih Oueriagli, Ayoub Dribla

Writing - original draft: Ayoub Dribla, Salah Nabih Oueriagli

Writing - review & editing: Salah Nabih Oueriagli, Abderrahim Doudouh

Ethics approval and consent to participate

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this case series, formal consent to participate is not required.

Consent for publication

Written informed consent was obtained from the patients for publication of this case series and any accompanying images.

Availability of data

Authors make available to all scientists, documents described in the manuscript, including new software, databases, and all relevant raw data.

References

[1]

Ullah E, Ahmad M, Ali SA, Redhu N. Primary hyperparathyroidism having multiple Brown tumors mimicking malignancy. Indian J Endocrinol Metab. 2012;16:1040-1042. doi: 10.4103/2230-8210.103037

[2]

Penhaat MG, Drui D, Ansquer C, Mirallie E, Maugars Y, Guillot P. Contribution of 18FDG PET/CT for the detection of brown tumors in a case of primary hyperparathyroidism. Rhum Rev. 2016;83:386.389. doi: 10.1016/j.rhum.2016.05.013

[3]

Tsukamoto S, Kawabata K, Kawamura H, Takata K, Hosono M. Differentiating brown tumor from bone metastasis in parathyroid cancer using 18F-FDG PET and 99mTc-MIBI SPECT. Clin Nucl Med. 2024; 49(5):444-446. doi: 10.1097/RLU.0000000000005115

[4]

Greilsamer T, Blanchard C, Christou N, et al. Management of thyroid nodules incidentally discovered on MIBI scanning for primary hyperparathyroidism. Langenbecks Arch Surg. 2015; 400:313-318. doi: 10.1007/s00423-015-1286-y

[5]

Santiago Chinchilla A, Ramos Font C, Muros de Fuentes MA, et al. False negative of the scintigraphy with 99mTc-sestamibi in parathyroid carcinoma with associated brown tumors. Contributions of the 18F-FDG-PET/CT. Rev Esp Med Nucl. 2011; 30:174-179. doi: 10.1016/j.remn.2010.08.006

[6]

Zhao Y, Wang Q. Bone uptake of Tc-99m MIBI in patients with hyperparathyroidism. Ann Nucl Med. 2014;28:349-355. doi: 10.1007/s12149-014-0818-9

[7]

Gedik GK, Ata O, Karabagli P, Sari O. Differential diagnosis between secondary and tertiary hyperparathyroidism in a case of a giant-cell and brown tumor containing mass. Findings by (99m)Tc-MDP, (18)F-FDG PET/CT and (99m) Tc-MIBI scans. Hell J Nucl Med. 2014;17:214-217. doi: 10.1967/s002449910147

[8]

Sager S, Aliyev A, Halac M, Oztürk T. Positron emission tomography/computed tomography imaging of brown tumors mimicking multiple skeletal metastases in patient with primary hyperparathyroidism. Indian J Endocrinol Metab. 2012;16:850-852. doi: 10.4103/2230-8210.100682

[9]

Zanglis A, Andreopoulos D, Zissimopoulos A, Baziotis N. Multiple brown tumors with Tc-99mMDP superscan appearance and negative Tc-99mMIBI uptake. Clin Nucl Med. 2006; 31:640-643. doi: 10.1097/01.rlu.0000237968.88074.fb

[10]

Geysen A, Van Laere K, Verscuren R. Detection of unexpected brown tumors due to hyperparathyroidism diagnosed by 18F-FDG PET/CT. Clin Nucl Med. 2021; 46(1):e16-e17. doi: 10.1097/RLU.000000000003380

[11]

Heimburger C, Andres E, Rust E, et al. Morpho-functional imaging in a patient with hyperparathyroidism and multifocal maxillary brown tumor. Rev Med Interne. 2013; 34:377-381. doi: 10.1016/j.revmed.2013.02.007

AI Summary AI Mindmap
PDF (1155KB)

130

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/